Background: Homocysteine (tHcy) has emerged as a new risk factor for cardiovascular diseases (CVD) The Methylenetetrahydrofolate reductase (MTHFR) polymorphisms are seen to give rise to high levels of tHcy which can be a causative factor in the progression of CVD due to its thrombogenic effect. Serum cardiac biomarkers help in the diagnosis, prognosis, or surveillance of CVD. The present study evaluated the association of the two MTHFR mutations, rs1801133 and rs1801131 with 16 well-established serum cardiac markers. Additionally, the influence of age and gender on the association of the two MTHFR polymorphisms with serum cardiac marker levels was also investigated. Methods: The study was carried out on 1295 individuals who visited Vibrant America Clinical Lab for regular or suspected CVD check-ups. The serological markers and genomic variant analysis were carried out as per the standard laboratory protocol under CLIA. The association between serological markers and the rs1801133 and rs1801131 genetic variants with respect to age and gender was evaluated using a one-way ANNOVA test. Results: No significant association was observed in tHcy levels with respect to gender, however, plasma total tHcy levels were higher in males than females. tHcy levels increased with increasing age in the wild and heterozygous genotypes for the mutations, rs1801133 and rs1801131. Additionally, the serum cardiac markers, High Density Lipoprotein (HDL), Low Density Lipoprotein (LDL), Cholesterol (CHOL), Apolipoprotein A (APOA), Apolipoprotein B (APOB), N-terminal (NT)-pro hormone BNP (BNPNT), LDL calculated (LDLCAL), Small Density Low Density Lipoprotein (SDLDL), APOBAR, Oxidised Low Density Lipoprotein (OXLDL), Lipoprotein (A) (LPA), Triglycerides (TRIG), and Lipoprotein-Associated Phospholipase (Lp-PLA2) Test (PLAC) showed significant associations with respect to gender and age for rs1801133 and rs1801131 (P < 0.05) However, these markers were seen to have different trends in correlation with gender and age. Conclusions: The present study reports the association of tHcy, HDL, LDL, CHOL, APOA, APOB, BNPNT, LDLCAL, SDLDL, APOBAR, OXLDL, LPA, TRIG, and PLAC with respect to age and gender for the mutations, rs1801133 and rs1801131. We observed that tHcy levels were high in males and the levels increased with increasing age in males for both polymorphisms. rs1801131 mutant males have high levels of triglyceride whereas rs1801133 mutant postmenopausal females showed high levels of cholesterol. Further analysis
References
[1]
Fletcher, O. and Kessling, A.M. (1998) MTHFR Association with Arteriosclerotic Vascular Disease? Human Genetics, 103, 11-21. https://doi.org/10.1007/s004390050776
[2]
Friedman, G., Goldschmidt, N., Friedlander, Y., Ben-Yehuda, A., Selhub, J., Babaey, S. and Bar-On, H. (1999) A Common Mutation A1298C in Human Methylenetetrahydrofolate Reductase Gene: Association with Plasma Total Homocysteine and Folate Concentrations. The Journal of Nutrition, 129, 1656-1661. https://doi.org/10.1093/jn/129.9.1656
[3]
D’Angelo, A. and Selhub, J. (1997) Homocysteine and Thrombotic Disease. Blood, The Journal of the American Society of Hematology, 90, 1-11. https://doi.org/10.1182/blood.V90.1.1
[4]
Frosst, P., Blom, H.J., Milos, R., Goyette, P., Sheppard, C.A., Matthews, R.G. and Rozen, R. (1995) A Candidate Genetic Risk Factor for Vascular Disease: A Common mutation in Methylenetetrahydrofolate Reductase. Nature Genetics, 10, 111-113. https://doi.org/10.1038/ng0595-111
[5]
Van der Put, N.M.J., Van den Heuvel, L.P., Steegers-Theunissen, R., Trijbels, F.J.M., Eskes, T.K.A.B., Mariman, E.C.M. and Blom, H.J. (1996) Decreased Methylene Tetrahydrofolate Reductase Activity Due to the 677C→ T Mutation in Families with Spina Bifida Offspring. Journal of Molecular Medicine, 74, 691-694. https://doi.org/10.1007/s001090050073
[6]
Weisberg, I., Tran, P., Christensen, B., Sibani, S. and Rozen, R. (1998) A Second Genetic Polymorphism in Methylenetetrahydrofolate Reductase (MTHFR) Associated with Decreased Enzyme Activity. Molecular Genetics and Metabolism, 64, 169-172. https://doi.org/10.1006/mgme.1998.2714
[7]
McCully, K. (1969) Vascular Pathology of Homocysteinemia: Implications for the Pathogenesis of Arteriosclerosis. The American Journal of Pathology, 56, 111-128.
[8]
North, B.J. and Sinclair, D.A. (2012) The Intersection between Aging and Cardiovascular Disease. Circulation Research, 110, 1097-1108. https://doi.org/10.1161/CIRCRESAHA.111.246876
[9]
Selhub, J. (1999) Homocysteine Metabolism. Annual Review of Nutrition, 19, 217-246. https://doi.org/10.1146/annurev.nutr.19.1.217
[10]
Russo, G.T., Friso, S., Jacques, P.F., Rogers, G., Cucinotta, D., Wilson, P.W. and Selhub, J. (2003) Age and Gender Affect the Relation between Methylenetetrahydrofolate Reductase C677T Genotype and Fasting Plasma Homocysteine Concentrations in the Framingham Offspring Study Cohort. The Journal of Nutrition, 133, 3416-3421. https://doi.org/10.1093/jn/133.11.3416
[11]
Sampson, M., Ling, C., Sun, Q., Harb, R., Ashmaig, M., Warnick, R. and Remaley, A.T. (2020) A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients with Normolipidemia and/or Hypertriglyceridemia. JAMA Cardiology, 5, 540-548. https://doi.org/10.1001/jamacardio.2020.0013
[12]
Ghatak, S., Muthukumaran, R.B. and Nachimuthu, S.K. (2013) A Simple Method of Genomic DNA Extraction from Human Samples for PCR-RFLP Analysis. Journal of Biomolecular Techniques, 24, 224-231. https://doi.org/10.7171/jbt.13-2404-001
[13]
Wang, H., Naghavi, M., Allen, C., Barber, R.M., Bhutta, Z.A., Carter, A. and Bell, M.L. (2016) Global, Regional, and National Life Expectancy, All-Cause Mortality, and Cause-Specific Mortality for 249 Causes of Death, 1980-2015: A Systematic Analysis for the Global Burden of Disease Study 2015. The lancet, 388, 1459-1544. https://doi.org/10.1016/S0140-6736(16)31012-1
[14]
Kathiresan, S. and Srivastava, D. (2012) Genetics of Human Cardiovascular Disease. Cell, 148, 1242-1257. https://doi.org/10.1016/j.cell.2012.03.001
[15]
Xu, R., Huang, F., Wang, Y., Liu, Q., Lv, Y. and Zhang, Q. (2020) Gender-and Age-Related Differences in Homocysteine Concentration: A Cross-Sectional Study of the General Population of China. Scientific Reports, 10, Article No. 17401. https://doi.org/10.1038/s41598-020-74596-7
[16]
McCully, K.S. and Carvalho, A.C. (1987) Homocysteine Thiolactone, N-Homocysteine Thiolactonyl Retinamide, and Platelet Aggregation. Research Communications in Chemical Pathology and Pharmacology, 56, 349-360.
[17]
Rodgers, G.M. and Conn, M.T. (1990) Homocysteine, an Atherogenic Stimulus, Reduces Protein C Activation by Arterial and Venous Endothelial Cells. Blood, 75, 895-901. https://doi.org/10.1182/blood.V75.4.895.895
[18]
Heinecke, J.W., Rosen, H., Suzuki, L.A. and Chait, A. (1987) The Role of Sulfur-Containing Amino Acids in Superoxide Production and Modification of Low Density Lipoprotein by Arterial Smooth Muscle Cells. Journal of Biological Chemistry, 262, 10098-10103. https://doi.org/10.1016/S0021-9258(18)61082-8
[19]
Fonseca, V., Guba, S.C. and Fink, L.M. (1999) Hyperhomocysteinemia and the Endocrine System: Implications for Atherosclerosis and Thrombosis. Endocrine Reviews, 20, 738-759. https://doi.org/10.1210/edrv.20.5.0381
[20]
Margalit, I., Cohen, E., Goldberg, E. and Krause, I. (2018) Vitamin B12 Deficiency and the Role of Gender: A Cross-Sectional Study of a Large Cohort. Annals of Nutrition and Metabolism, 72, 265-271. https://doi.org/10.1159/000488326
[21]
Munshi, M.N., Stone, A., Fink, L. and Fonseca, V. (1996) Hyperhomocysteinemia Following a Methionine Load in Patients with Non-Insulin-Dependent Diabetes mellitus and Macrovascular Disease. Metabolism, 45, 133-135. https://doi.org/10.1016/S0026-0495(96)90211-5
[22]
Jacques, P.F., Rosenberg, I.H., Rogers, G., Selhub, J., Bowman, B.A., Gunter, E. W. and Johnson, C.L. (1999) Serum Total Homocysteine Concentrations in Adolescent and Adult Americans: Results from the Third National Health and Nutrition Examination Survey. The American Journal of Clinical Nutrition, 69, 482-489. https://doi.org/10.1093/ajcn/69.3.482
[23]
Zhang, Z., Gu, X., Fang, X., Tang, Z., Guan, S., Liu, H. and Zhao, Y. (2020) Homocysteine and the Risk of Cardiovascular Events and All-Cause Death in Elderly Population: A Community-Based Prospective Cohort Study. Therapeutics and Clinical Risk Management, 16, 471-481. https://doi.org/10.2147/TCRM.S239496
[24]
Yao, Y., Gao, L.J., Zhou, Y., Zhao, J.H., Lv, Q., Dong, J.Z. and Shang, M.S. (2017) Effect of Advanced Age on Plasma Homocysteine Levels and Its Association with Ischemic Stroke in Non-Valvular Atrial Fibrillation. Journal of Geriatric Cardiology, 14, 743-749.
[25]
Cho, S.E., Hong, K.S., Shin, G.J. and Chung, W.S. (2006) The Methylenetetrahydrofolate Reductase C677T Gene Mutation Is Associated with Hyperhomocysteinemia, Cardiovascular Disease and Plasma B-Type Natriuretic Peptide Levels in Korea. Clinical Chemistry and Laboratory Medicine (CCLM), 44, 1070-1075. https://doi.org/10.1515/CCLM.2006.194
[26]
Jousilahti, P., Vartiainen, E., Tuomilehto, J. and Puska, P. (1999) Sex, Age, Cardiovascular Risk Factors, and Coronary Heart Disease: A Prospective Follow-Up Study of 14 786 Middle-Aged Men and Women in Finland. Circulation, 99, 1165-1172. https://doi.org/10.1161/01.CIR.99.9.1165
[27]
Anagnostis, P., Stevenson, J.C., Crook, D., Johnston, D.G. and Godsland, I.F. (2016) Effects of Gender, Age and Menopausal Status on Serum Apolipoprotein Concentrations. Clinical Endocrinology, 85, 733-740. https://doi.org/10.1111/cen.13085
[28]
Kim, M.K., Han, K., Joung, H.N., Baek, K.H., Song, K.H. and Kwon, H.S. (2019) Cholesterol Levels and Development of Cardiovascular Disease in Koreans with Type 2 Diabetes Mellitus and without Pre-Existing Cardiovascular Disease. Cardiovascular Diabetology, 18, Article No. 139. https://doi.org/10.1186/s12933-019-0943-9
[29]
Redfield, M.M., Rodeheffer, R.J., Jacobsen, S.J., Mahoney, D.W., Bailey, K.R. and Burnett, J.C. (2002) Plasma Brain Natriuretic Peptide Concentration: Impact of Age and Gender. Journal of the American College of Cardiology, 40, 976-982. https://doi.org/10.1016/S0735-1097(02)02059-4
